Provided by Tiger Trade Technology Pte. Ltd.

Chemours

15.39
-0.5800-3.63%
Post-market: 15.390.00000.00%19:30 EDT
Volume:1.49M
Turnover:22.95M
Market Cap:2.31B
PE:-7.62
High:15.90
Open:15.90
Low:15.25
Close:15.97
52wk High:28.67
52wk Low:10.44
Shares:149.89M
Float Shares:148.93M
Volume Ratio:0.86
T/O Rate:1.00%
Dividend:0.35
Dividend Rate:2.27%
EPS(TTM):-2.0200
EPS(LYR):-2.5700
ROE:-319.37%
ROA:1.42%
PB:-47.08
PE(LYR):-5.99

Loading ...

Chemours Down over 17%, on Pace for Largest Percent Decrease Since February 2024

Dow Jones
·
Aug 06

Chemours: Cyclical Trough Nearing, Margin Strength Supports Buy Rating with Unchanged $26 Price Target

TIPRANKS
·
Aug 05

Analysts Conflicted on These Materials Names: SSR Mining (SSRM), Olin (OLN) and Chemours Company (CC)

TIPRANKS
·
Aug 05

Ecovyst Beats Q2 Sales Estimates, Raises FY Guidance

Reuters
·
Aug 05

The Chemours Company Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 05

Chemours Co Q2 Adjusted Earnings, Revenue Fall; Guides Q3

MT Newswires Live
·
Aug 05

Chemours Q2 FY26 Net Loss Narrows 28% to $274 Million; Net Sales Slip 1% to $1.59 Billion

Reuters
·
Aug 05

Chemours Declares Q3 Dividend of $0.0875 a Share

Reuters
·
Aug 05

Chemours Q2 Sales Flat as Lower Volumes Weigh on Results

Reuters
·
Aug 05

Chemours sees FY26 revenue growth 1%-5% vs. FY25, consensus $6.05B

TIPRANKS
·
Aug 05

Chemours reports Q2 adjusted EPS 42c, consensus 42c

TIPRANKS
·
Aug 05

Chemours Q2 Adj. EPS $0.42, Inline, Sales $1.591B Miss $1.654B Estimate

Benzinga Earnings
·
Aug 05

Chemours Q2 Adjusted EPS USD 0.42 Vs. IBES Estimate USD 0.42

Reuters
·
Aug 05

Press Release: Chemours Announces Third Quarter Dividend

Dow Jones
·
Aug 05

Chemours: in Q3, Co Expects Consolidated Net Sales to Decrease in Range of 5% to Flat

THOMSON REUTERS
·
Aug 05

Chemours: Continues to Expect 2026 Net Sales to Grow in Range of 1% to 5% over 2025

THOMSON REUTERS
·
Aug 05

Chemours Co Q3 REV View $1.60 Bln

THOMSON REUTERS
·
Aug 05

Chemours Co Fy2026 REV View $6.04 Bln

THOMSON REUTERS
·
Aug 05

Carlsmed Announces Favorable Reimbursement for aprevo® lumbar Procedures

GlobeNewswire
·
Aug 03

Earning Preview: Chemours Q2 revenue is expected to increase by 5.66%, and institutional views are constructive

Earnings Agent
·
Jul 29